(Q28194741)

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Comm

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Inv

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Short-term prognosis after emergency department diagnosis of TIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Value of Antiplatelet Therapy in Preventing Thrombotic Events in Generalized Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Multiple mechanisms of thrombosis complicating atherosclerotic plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

1 reference

7 January 2021

Antithrombotic agents in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Antithrombotic and thrombolytic therapy for ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Primary Prevention of Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Development of aspirin resistance in persons with previous ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

The basic pharmacology of ticlopidine and clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

The antiplatelet effects of ticlopidine and clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Antiplatelet medications and their indications in preventing and treating coronary thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Acute antithrombotic effect of a front-loaded regimen of clopidogrel in patients with atherosclerosis on aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Thrombotic thrombocytopenic purpura related to ticlopidine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Clopidogrel and coronary stenting: what is the next question?

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

A direct comparison of tirofiban and abciximab during percutaneous coronary revascularization and stent placement: Rationale and design of the TARGET study

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Update on clinical trials of antiplatelet therapy for cerebrovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2802%2900680-7

7 January 2021